Brand X lets a gumshoe do the selling

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, along with some clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Ave 2: The Story of Medical Advertising in America 1990-2008. Please e-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is February 29, 2012. The winner will be selected randomly from all the correct entries.

Brand X got bad news last month, a mini-PR crisis that could help some would-be users rationalize their decision to procrastinate on taking the OTC drug. The brand, a line extension of the category leader that competes with a myriad of non-prescription products and several prescription drugs, launched in 2010 and is now running cheeky ads, some with a celebratory vibe and a ‘70s funk-flavored flair. It's a small product, but as OTC brands go, takes in a pretty big haul and helps users quit a deadly behavior.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.